FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000508004: Great Britain English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001112010 Great Britain English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001113017 GB English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001114011 Great Britain English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


1327206 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
GB English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
16p12.2 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
16p13.11 microdeletion syndrome Preferred (foundation metadata concept)
16p13.11 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
16p13.11 microdeletion syndrome is a recently described syndrome characterised by developmental delay, microcephaly, epilepsy, short stature, facial dysmorphism and behavioural problems. Preferred (foundation metadata concept)
16p13.11 microduplication syndrome Preferred (foundation metadata concept)
16p13.11 microduplication syndrome (disorder) Preferred (foundation metadata concept)
16p13.11 microduplication syndrome is a recently described syndrome associated with variable clinical features including behavioural abnormalities, developmental delay, congenital heart defects and skeletal anomalies. Preferred (foundation metadata concept)
16p13.2 microdeletion syndrome Acceptable (foundation metadata concept)
16p13.3 microduplication syndrome Preferred (foundation metadata concept)
16p13.3 microduplication syndrome (disorder) Preferred (foundation metadata concept)
16p13.3 microduplication syndrome is a rare chromosomal anomaly syndrome resulting from a partial duplication of the short arm of chromosome 16 and manifesting with a variable phenotype which is mostly characterised by: mild to moderate intellectual deficit and developmental delay (particularly speech), normal growth, short, proximally implanted thumbs and other hand and feet malformations (such as camptodactyly, syndactyly, club feet), mild arthrogryposis and characteristic facies (upslanting, narrow palpebral fissures, hypertelorism, mid face hypoplasia, bulbous nasal tip and low set ears). Other reported manifestations include cryptorchidism, inguinal hernia and behavioural problems. Preferred (foundation metadata concept)
16q partial monosomy syndrome Preferred (foundation metadata concept)
16q partial monosomy syndrome (disorder) Preferred (foundation metadata concept)
16q partial trisomy syndrome Preferred (foundation metadata concept)
16q partial trisomy syndrome (disorder) Preferred (foundation metadata concept)
16q24.1 microdeletion syndrome Preferred (foundation metadata concept)
16q24.1 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
16q24.3 microdeletion syndrome Preferred (foundation metadata concept)
16q24.3 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
16q24.3 microdeletion syndrome is a recently described syndrome associated with variable developmental delay, facial dysmorphism, seizures and autistic spectrum disorder. Preferred (foundation metadata concept)
16x/day Acceptable (foundation metadata concept)
17 Preferred (foundation metadata concept)
17 (AJCC) Acceptable (foundation metadata concept)
17 (UICC) Acceptable (foundation metadata concept)
17 (qualifier value) Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement (procedure) Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement, amniotic fluid Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement, amniotic fluid (procedure) Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement, serum Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement, serum (procedure) Preferred (foundation metadata concept)
17 OHP - 17-hydroxyprogesterone Acceptable (foundation metadata concept)
17 alpha-Hydroxylase deficiency Acceptable (foundation metadata concept)
17 alpha-Hydroxyprogesterone aldolase deficiency Preferred (foundation metadata concept)
17 alpha-Hydroxyprogesterone aldolase deficiency (disorder) Preferred (foundation metadata concept)
17 alpha-hydroxyprogesterone Preferred (foundation metadata concept)
17 alpha-hydroxyprogesterone Acceptable (foundation metadata concept)
17 alpha-hydroxyprogesterone (substance) Preferred (foundation metadata concept)
17 beta-estradiol (substance) Preferred (foundation metadata concept)
17 beta-estradiol preparation (product) Preferred (foundation metadata concept)
17 beta-hydroxysteroid dehydrogenase Acceptable (foundation metadata concept)
17 beta-oestradiol Preferred (foundation metadata concept)
17 beta-oestradiol preparation Preferred (foundation metadata concept)
17,18,21-trihydroxypregn-4-ene-3,11,20-trione Acceptable (foundation metadata concept)
17,21-dihydroxypregnenolone Preferred (foundation metadata concept)
17,21-dihydroxypregnenolone (substance) Preferred (foundation metadata concept)
17,21-hydroxyprogesterone Acceptable (foundation metadata concept)
17-Beta-estriol Preferred (foundation metadata concept)
17-Beta-estriol (substance) Preferred (foundation metadata concept)
17-Hydroxycorticosteroid Preferred (foundation metadata concept)
17-Hydroxycorticosteroid (substance) Preferred (foundation metadata concept)
17-Hydroxyketosteroids measurement Preferred (foundation metadata concept)
17-Hydroxyketosteroids measurement (procedure) Preferred (foundation metadata concept)
17-Hydroxypregnenolone measurement Preferred (foundation metadata concept)
17-Hydroxypregnenolone measurement (procedure) Preferred (foundation metadata concept)
17-KGS measurement Acceptable (foundation metadata concept)
17-KS measurement Acceptable (foundation metadata concept)
17-KS measurement, fractionation Acceptable (foundation metadata concept)
17-KSR deficiency Acceptable (foundation metadata concept)
17-Ketogenic steroid Preferred (foundation metadata concept)
17-Ketogenic steroid (substance) Preferred (foundation metadata concept)
17-Ketogenic steroids measurement Preferred (foundation metadata concept)
17-Ketogenic steroids measurement (procedure) Preferred (foundation metadata concept)
17-Ketosteroid reductase deficiency Acceptable (foundation metadata concept)
17-Ketosteroids Acceptable (foundation metadata concept)
17-Ketosteroids measurement Preferred (foundation metadata concept)
17-Ketosteroids measurement (procedure) Preferred (foundation metadata concept)
17-Ketosteroids measurement, fractionation, urine Preferred (foundation metadata concept)
17-Ketosteroids measurement, fractionation, urine (procedure) Preferred (foundation metadata concept)
17-Ketosteroids measurement, total Preferred (foundation metadata concept)
17-Ketosteroids measurement, total (procedure) Preferred (foundation metadata concept)
17-O-deacetylvindoline O-acetyltransferase Preferred (foundation metadata concept)
17-O-deacetylvindoline O-acetyltransferase (substance) Preferred (foundation metadata concept)
17-OHCS measurement Acceptable (foundation metadata concept)
17-Oxogenic steroid Acceptable (foundation metadata concept)
17-Oxosteroid Preferred (foundation metadata concept)
17-Oxosteroid (substance) Preferred (foundation metadata concept)
17-alpha-18,21-trihydroxypregn-4-ene-3,20-dione Acceptable (foundation metadata concept)
17-alpha-hydroxypregnenolone Acceptable (foundation metadata concept)
17-beta estradiol Acceptable (foundation metadata concept)
17-hydrocorticosteroid Acceptable (foundation metadata concept)
17-hydroxycorticoid Acceptable (foundation metadata concept)
17-hydroxycorticosteroid Preferred (foundation metadata concept)
17-hydroxycorticosteroid (substance) Preferred (foundation metadata concept)
17-hydroxycorticosteroid measurement Preferred (foundation metadata concept)
17-hydroxycorticosteroid measurement (procedure) Preferred (foundation metadata concept)
17-hydroxylase Acceptable (foundation metadata concept)
17-hydroxypregnenolone Preferred (foundation metadata concept)
17-hydroxypregnenolone (substance) Preferred (foundation metadata concept)
17-hydroxyprogesterone Preferred (foundation metadata concept)
17-hydroxyprogesterone (substance) Preferred (foundation metadata concept)
17-ketogenic steroid Preferred (foundation metadata concept)
17-ketogenic steroid (substance) Preferred (foundation metadata concept)
17-ketogenic steroids level above reference range Preferred (foundation metadata concept)
17-ketogenic steroids level above reference range (finding) Preferred (foundation metadata concept)
17-ketogenic steroids level below reference range Preferred (foundation metadata concept)
17-ketogenic steroids level below reference range (finding) Preferred (foundation metadata concept)
17-ketogenic steroids within reference range Preferred (foundation metadata concept)
17-ketogenic steroids within reference range (finding) Preferred (foundation metadata concept)
17-ketosteroid Preferred (foundation metadata concept)
17-ketosteroid (substance) Preferred (foundation metadata concept)

Start Previous Page 74 of 13273 Next End


Reference Sets

Reference set descriptor

Back to Start